Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1261013 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR33485771_1.fastq.gz | Fastqsanger.gz | |||
| SRR33485772_1.fastq.gz | Fastqsanger.gz | |||
| SRR33485773_1.fastq.gz | Fastqsanger.gz | |||
| SRR33485774_1.fastq.gz | Fastqsanger.gz | |||
| SRR33485775_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 28 |
Similar Datasets
Project description:Tuberculosis (TB) and non-tuberculous mycobacterial (NTM) infections, though clinically similar, require distinct management, highlighting the need for reliable biomarkers to differentiate them. In a study of 108 patients, 16S rRNA sequencing revealed distinct microbial signatures, with Enterococcus faecalis, Streptococcus mutans, and Snodgrassella alvi associated with TB, and Cardiobacterium hominis and Prevotella nigrescens linked to NTM. The absence of Mobiluncus curtisii, particularly with Olsenella phocaeensis also absent, suggested a higher probability of NTM, offering promising insights for diagnostic and therapeutic advancements.
2025-12-02 | GSE278953 | GEO
Project description:Objectives: Central nervous system (CNS) infections are common causes of morbidity and mortality worldwide. We aimed to discover protein biomarkers that could rapidly and accurately identify the likely cause of the infections, essential for clinical management and improving outcome. Methods: We applied liquid chromatography tandem mass-spectrometry on 45 cerebrospinal fluid (CSF) samples from a cohort of adults with/without CNS infections to discover potential diagnostic biomarkers. We then validated the diagnostic performance of a selected biomarker candidate in an independent cohort of 364 consecutively treated adults with CNS infections admitted to a referral hospital in Vietnam. Results: In the discovery cohort, we identified lipocalin 2 (LCN2) as a potential biomarker of bacterial meningitis (BM) other than tuberculous meningitis. The analysis of the validation cohort showed that LCN2 could discriminate BM from other CNS infections (including tuberculous meningitis, cryptococcal meningitis and viral/antibody-mediated encephalitis), with the sensitivity: 0.88 (95% confident interval (CI): 0.77-0.94), the specificity: 0.91 (95%CI: 0.88-0.94) and the diagnostic odd ratio: 73.8 (95%CI: 31.8-171.4)). LCN2 outperformed other CSF markers (leukocytes, glucose, protein and lactate) commonly used in routine care worldwide. The combination of LCN2, CSF leukocytes, glucose, protein and lactate resulted in the highest diagnostic performance for BM (area under receiver-operating-characteristic-curve 0.96; 95%CI: 0.93-0.99). Conclusions: Our results suggest that LCN2 is a sensitive and specific biomarker for discriminating BM from a broad spectrum of other CNS infections. A prospective study is needed to assess the diagnostic utility of LCN2 in the diagnosis and management of CNS infections..
2020-08-20 | PXD020510 | Pride
Project description:Lyme neuroborreliosis (LNB) is a nervous system infection caused by tick-borne spirochetes of the Borrelia burgdorferi sensu lato complex and is one of the most frequent bacterial infections of the nervous system in Europe. Early diagnosis remains challenging due to limited sensitivity and specificity of current tests and the need for invasive lumbar punctures, highlighting the need for improved and potentially less invasive diagnostic tools. In this study, we used bottom-up proteomics to analyze 308 cerebrospinal fluid (CSF) samples and 207 plasma samples from well-characterized cohorts, including patients with LNB, viral meningitis, other manifestations of Lyme borreliosis without central nervous system involvement, and controls with normal CSF findings. We identified diagnostic panels of regulated proteins and evaluated their performance using machine learning–based classifiers. The resulting models distinguished LNB from viral meningitis and controls in CSF with areas under the ROC curve (AUC) of 0.92 and 0.90, respectively. In plasma, LNB was distinguished from controls with an AUC of 0.80. These findings suggest a potential diagnostic role for proteomics-based biomarker panels in LNB and provide a large-scale, publicly available proteomic resource for further biomarker discovery and validation studies. NOTE the CSF search and raw files can be found in PXD067474.
2025-09-30 | PXD067583 | Pride
Project description:Lyme neuroborreliosis (LNB) is a nervous system infection caused by tick-borne spirochetes of the Borrelia burgdorferi sensu lato complex and is one of the most frequent bacterial infections of the nervous system in Europe. Early diagnosis remains challenging due to limited sensitivity and specificity of current tests and the need for invasive lumbar punctures, highlighting the need for improved and potentially less invasive diagnostic tools. In this study, we used bottom-up proteomics to analyze 308 cerebrospinal fluid (CSF) samples and 207 plasma samples from well-characterized cohorts, including patients with LNB, viral meningitis, other manifestations of Lyme borreliosis without central nervous system involvement, and controls with normal CSF findings. We identified diagnostic panels of regulated proteins and evaluated their performance using machine learning–based classifiers. The resulting models distinguished LNB from viral meningitis and controls in CSF with areas under the ROC curve (AUC) of 0.92 and 0.90, respectively. In plasma, LNB was distinguished from controls with an AUC of 0.80. These findings suggest a potential diagnostic role for proteomics-based biomarker panels in LNB and provide a large-scale, publicly available proteomic resource for further biomarker discovery and validation studies. NB: the plasma submission is seperate to this CSF submission
2025-09-30 | PXD067474 | Pride
Project description:Genomic transcriptional profiling of central nervous system infections with rabies virus
| PRJNA287877 | ENA
Project description:In this study, we performed a comparative analysis of gut microbiota composition and gut microbiome-derived bacterial extracellular vesicles (bEVs) isolated from patients with solid tumours and healthy controls. After isolating bEVs from the faeces of solid tumour patients and healthy controls, we performed spectrometry analysis of their proteomes and next-generation sequencing (NGS) of the 16S gene. We also investigated the gut microbiomes of faeces from patientsand controls using 16S rRNA sequencing. Machine learning was used to classify the samples into patients and controls based on their bEVs and faecal microbiomes.
2024-08-08 | PXD047510 | Pride
Project description:Gut microbiota were assessed in 540 colonoscopy-screened adults by 16S rRNA gene sequencing of stool samples. Investigators compared gut microbiota diversity, overall composition, and normalized taxon abundance among these groups.
| 2255499 | ecrin-mdr-crc